<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A12B/A
AMENDMENT TO APPLICATION OR REPORT
Filed pursuant to Section 12(b) or (g) of
THE SECURITIES EXCHANGE ACT OF 1934
DEKALB Genetics Corporation
----------------------------------------------------
(Exact name of registrant as specified in its charter)
AMENDMENT NO. 1
The undersigned registrant hereby amends the following item on the
Form 8-A on the pages attached hereto:
Signature Page
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this amendment to be signed on its
behalf by the undersigned, thereunto duly authorized.
SIGNATURE
Thomas R. Rauman
--------------------------
Thomas R. Rauman
Vice President-Finance
Chief Financial Officer
Date: May 23, 1997
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized.
DEKALB GENETICS CORPORATION
Date: May 23, 1997 By: Thomas R. Rauman
------------------------------
Thomas R. Rauman
Title: Vice President, Finance and
Chief Financial Officer
